SAGA DIAGNOSTICS
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits. The S... AGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
SAGA DIAGNOSTICS
Industry:
Biotechnology Genetics Medical
Founded:
2016-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.sagadiagnostics.com
Total Employee:
11+
Status:
Active
Contact:
+46 (0)733 01 7242
Email Addresses:
[email protected]
Total Funding:
17.96 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Segulah Medical Acceleration
Segulah Medical Acceleration investment in Series A - SAGA Diagnostics
Sciety
Sciety investment in Series A - SAGA Diagnostics
Hadean Ventures
Hadean Ventures investment in Series A - SAGA Diagnostics
Faro Capital
Faro Capital investment in Series A - SAGA Diagnostics
Hadean Ventures
Hadean Ventures investment in Series A - SAGA Diagnostics
Gunnar Nilsson Cancer Foundation
Gunnar Nilsson Cancer Foundation investment in Series A - SAGA Diagnostics
Simon Fredriksson
Simon Fredriksson investment in Seed Round - SAGA Diagnostics
Torna Kapital
Torna Kapital investment in Seed Round - SAGA Diagnostics
Christer Fahraeus
Christer Fahraeus investment in Seed Round - SAGA Diagnostics
Gunnar Nilsson Cancer Foundation
Gunnar Nilsson Cancer Foundation investment in Seed Round - SAGA Diagnostics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-07 | SAGA Diagnostics appoints Peter Collins as Chief Executive Officer |
Official Site Inspections
http://www.sagadiagnostics.com Semrush global rank: 9.4 M Semrush visits lastest month: 163
- Host name: linux2197.grserver.gr
- IP address: 213.158.90.7
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "SAGA Diagnostics"
Home - SAGA Diagnostics
This important work was translated into two interventional phase three studies with AstraZeneca (the MERMAID studies). Chris subsequently took up a position with AstraZeneca as a Senior …See details»
SAGA Diagnostics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +46 (0)733 01 7242 SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on …See details»
SAGA Diagnostics - Overview, News & Similar companies
Dec 30, 2021 View SAGA Diagnostics (www.sagadiagnostics.com) location in Skane, Sweden , revenue, industry and description. Find related and similar companies as well as employees …See details»
SAGA Diagnostics AB Management Team | Org Chart
Sagadiagnostics.com; View Similar People. Related Companies RED GLEAD DISCOVERY. 57 $6m SARomics Biostructures AB. 32 $1m AcouSort AB. 21 $1m EXINI Diagnostics. 17 $4m …See details»
SAGA Diagnostics - LinkedIn
SAGA Diagnostics | 3,120 followers on LinkedIn. Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency. | SAGA Diagnostics is a …See details»
SAGA Diagnostics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for SAGA Diagnostics. Use the PitchBook Platform to explore the full profile.See details»
Saga Diagnostics - Company Profile - Tracxn
Nov 29, 2024 Saga Diagnostics - Provider of tests for detection and analysis of circulating tumor DNA. Raised a total funding of $17.9M over 6 rounds from 12 investors. Founded by Lao Saal …See details»
SAGA Diagnostics - Craft
SAGA Diagnostics has 5 employees at their 1 location and $5.52 m in total funding,. See insights on SAGA Diagnostics including office locations, competitors, revenue, financials, executives, …See details»
SAGA Diagnostics CEO and Key Executive Team | Craft.co
SAGA Diagnostics's Chief Executive Officer is Peter Collins. Other executives include Anthony George, Co-Founder, CTO; Lao Saal, Founder and Chief Operating Officer and 7 others. See …See details»
SAGA Diagnostics - LinkedIn
SAGA Diagnostics | 2,849 followers on LinkedIn. Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency. | SAGA Diagnostics is a …See details»
SAGA Diagnostics Company Overview, Contact Details
Burgeoning Market SAGA Diagnostics operates in the biotechnology research industry, which is experiencing significant growth driven by the increasing demand for personalized cancer …See details»
SAGA Diagnostics - Crustdata Company Profile, Funding and Growth
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA …See details»
SAGA Diagnostics - Products, Competitors, Financials, Employees ...
Companies like Qiagen, Biocept, and Canexia Health are leading this trend with innovative solutions for drug administration in breast cancer treatment. The World Health Organization …See details»
Posters and Publications - SAGA Diagnostics
Jun 2, 2024 This important work was translated into two interventional phase three studies with AstraZeneca (the MERMAID studies). Chris subsequently took up a position with AstraZeneca …See details»
SAGA Diagnostics - Medicon Village
SAGA Diagnostics AB is a personalized cancer genomics and disease monitoring company that offers molecular genetic testing of tissue biopsies and non-invasive “liquid biopsies” such as …See details»
SAGA Diagnostics - CB Insights
CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve …See details»
SAGA Diagnostics enters into an assay development agreement …
Nov 2, 2021 Contact: COO Lao Saal, MD PhD, [email protected], Phone: +46(0)733-01-7242 About SAGA Diagnostics AB.See details»
Segulah Medical Acceleration Announces Investment in SAGA …
Jun 30, 2021 Navinci appoints Eva Pisa as chairman, further strengthens the leadership team and establishes a Scientific Advisory Board 2023.02.20. In line with the company’s vision of …See details»
SAGA Diagnostics raises €10.5 million - Hadean Ventures
Jun 29, 2021 SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasensitive cancer liquid biopsies. LUND, Sweden and STOCKHOLM, …See details»
Saga Diagnostics raises $4.1M for its ultrasensitive cancer blood …
Jun 13, 2019 Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive liquid biopsy tests for the monitoring of cancer treatments.See details»